(Total Views: 313)
Posted On: 08/13/2020 12:35:48 PM
Post# of 63

$BPTH News Article - Bio-Path Holdings Announces First Patient Dosed in Amended Stage 2 of the Phase 2 Clinical Trial Evaluating Prexigebersen in Acute Myeloid Leukemia https://marketwirenews.com/news-releases/bio-...26551.html


My Twitter: WhyteStocks